Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare’s Board of Directors grants an inducement award to Carrie Lazorchak, Definitive Healthcare’s new Chief Revenue Officer.
Definitive Healthcare reports financial results for third quarter fiscal year 2023
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended September 30, 2023.
Definitive Healthcare announces timing of its third quarter 2023 financial results conference call and webcast
Definitive Healthcare (Nasdaq: DH) will report its third-quarter financial results on Thursday, November 2, 2023 at 5:00 p.m. ET.
Definitive Healthcare names Carrie Lazorchak as Chief Revenue Officer
Definitive Healthcare announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023.
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare’s Board of Directors grants inducement awards to former employees of Populi.
Definitive Healthcare welcomes Scott Stephenson to Board of Directors
Scott Stephenson, the former Chief Executive Officer of Verisk Analytics, joins Definitive Healthcare’s Board of Directors.
Definitive Healthcare to present at the Morgan Stanley 21st Annual Global Healthcare Conference
Definitive Healthcare’s CEO Robert Musslewhite and CFO Rick Booth will present at the Morgan Stanley 21st Annual Global Healthcare Conference.
Definitive Healthcare reports financial results for second quarter fiscal year 2023
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended June 30, 2023.
Definitive Healthcare expands Atlas Technology Install Dataset
Definitive Healthcare expands Atlas Technology Install Dataset with more than 1.7 million updates to technology installations for hospitals, health…